未登录Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial接受帕妥珠单抗再治疗患者的生活质量：PRECIOUS试验的二次分析
Taira, Naruto; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Takahashi, Masato; Yoshinami, Tetsuhiro; Ueno, Takayuki; Toyama, Tatsuya; Takano, Toshimi; Kashiwaba, Masahiro; Tsugawa, Koichiro; Tada, Hiroshi; Hara, Fumikata; Fujisawa, Tomomi; Niikura, Naoki; Morita, Satoshi; Masuda, Norikazu .png)
分享.png)
收藏分享 收藏 分享 收藏 Predictive factors and prognostic significance of HER2-low early breast cancer with long-term follow-upHER2低表达早期乳腺癌的预测因素及长期随访预后意义Niwa, Yuka; Terada, Mitsuo; Wanifuchi-Endo, Yumi; Fujita, Takashi; Asano, Tomoko; Kawaguchi, Hidetoshi; Nozawa, Kazuki; Matsumoto, Nana; Isogai, Ayaka; Kawahara, Hikaru; Mizumoto, Marie; Toyama, Tatsuya 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer激素受体阳性、HER2阴性早期乳腺癌辅助S-1疗法最适宜的患者人群Isogai, Ayaka; Terada, Mitsuo; Wanifuchi-Endo, Yumi; Fujita, Takashi; Asano, Tomoko; Mori, Makiko; Nozawa, Kazuki; Matsumoto, Nana; Niwa, Yuka; Tanaka, Yuya; Kato, Hiroyuki; Komura, Masayuki; Toyama, Tatsuya 分享 收藏 Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-upER-intermediate-positive乳腺癌患者长期随访的预后、临床病理特征及治疗模式Matsumoto, N.; Wanifuchi-Endo, Y.; Fujita, T.; Asano, T.; Terada, M.; Nozawa, K.; Mori, M.; Isogai, A.; Niwa, Y.; Kato, H.; Komura, M.; Toyama, T. 分享 收藏 Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trialTokunaga, Eriko; Iwata, Hiroji; Itoh, Mitsuya; Taira, Tetsuhiko; Toyama, Tatsuya; Mizuno, Toshiro; Osaki, Akihiko; Yanagita, Yasuhiro; Nakamura, Seigo; Nakamura, Rikiya; Sambe, Tomoko; Ozaki, Toshiaki; Schiavon, Gaia; Howell, Sacha J.; Toi, Masakazu 分享 收藏 Prognostic impact of AKAP8 expression in breast cancer patientsMatsumoto, N.; Kato, A.; Wanifuchi, Y.; Fuzita, T.; Asano, T.; Horisawa, N.; Mori, M.; Isogai, A.; Ogawa, R.; Toyama, T. 分享 收藏 分享 收藏 分享 收藏 The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment (vol 31, pg 340, 2024)Yamamoto, Yutaka; Yamauchi, Chikako; Toyama, Tatsuya; Nagai, Shigenori; Sakai, Takehiko; Kutomi, Goro; Yoshimura, Michio; Kawai, Masaaki; Ohtani, Shoichiro; Kubota, Kazunori; Nakashima, Kazutaka; Honma, Naoko; Yoshida, Masayuki; Tokunaga, Eriko; Taira, Naruto; Iwata, Hiroji; Saji, Shigehira 分享 收藏 The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment日本乳腺癌学会乳腺癌临床实践指南，2022版: 2018版的变化和乳腺癌治疗的一般声明Yamamoto, Yutaka; Yamauchi, Chikako; Toyama, Tatsuya; Nagai, Shigenori; Sakai, Takehiko; Kutomi, Goro; Yoshimura, Michio; Kawai, Masaaki; Ohtani, Shoichiro; Kubota, Kazunori; Nakashima, Kazutaka; Honma, Naoko; Yoshida, Masayuki; Tokunaga, Eriko; Taira, Naruto; Iwata, Hiroji; Saji, Shigehira 分享 收藏 Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X)Kusudo, Maho; Terada, Mitsuo; Kureyama, Nari; Wanifuchi-Endo, Yumi; Fujita, Takashi; Asano, Tomoko; Kato, Akiko; Mori, Makiko; Horisawa, Nanae; Toyama, Tatsuya 分享 收藏 Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study)Akechi, Tatsuo; Furukawa, Toshiaki A.; Noma, Hisashi; Iwata, Hiroji; Toyama, Tatsuya; Higaki, Kenji; Matsuoka, Hiromichi; Zenda, Sadamoto; Iwatani, Tsuguo; Akahane, Kazuhisa; Inoue, Akira; Sagara, Yasuaki; Uchida, Megumi; Imai, Fuminobu; Momino, Kanae; Imaizumi, Gen; Yamaguchi, Takuhiro; Mashiko, Tomoe; Miyaji, Tempei; Horikoshi, Masaru; Sakurai, Naomi; Onishi, Tatsuya; Kanemitsu, Yukihide; Murata, Takeshi; Wanifuchi-Endo, Yumi; Kuroda, Hiroaki; Nishikawa, Ryutaro; Miyashita, Minoru; Abe, Masakazu; Uchitomi, Yosuke 分享 收藏 Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice GuidelinesHattori, Masaya; Honma, Naoko; Nagai, Shigenori; Narui, Kazutaka; Shigechi, Tomoko; Ozaki, Yukinori; Yoshida, Masayuki; Sakatani, Takashi; Sasaki, Eiichi; Tanabe, Yuko; Tsurutani, Junji; Takano, Toshimi; Saji, Shigehira; Masuda, Shinobu; Horii, Rie; Tsuda, Hitoshi; Yamaguchi, Rin; Toyama, Tatsuya; Yamauchi, Chikako; Toi, Masakazu; Yamamoto, Yutaka 分享 收藏 Phase 1/2 study of HER3-DXd in HER3-expressing metastatic breast cancer: Subgroup analysis by HER2 expressionIwata, Hiroji; Krop, Ian E.; Masuda, Norikazu; Mukohara, Toru; Takahashi, Shunji; Nakayama, Takahiro; Inoue, Kenichi; Toyama, Tatsuya; Yamamoto, Yutaka; Alvarez, Ricardo H.; Takahashi, Masato; Osaki, Akihiko; Ohwada, Shoichi; Mostillo, Joseph; Tanaka, Yoshimi; Sternberg, David; Sellami, Dalila 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
